Focus Partners Wealth Buys 26,270 Shares of Intuitive Surgical, Inc. $ISRG

Focus Partners Wealth raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 49.5% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 79,306 shares of the medical equipment provider’s stock after acquiring an additional 26,270 shares during the period. Focus Partners Wealth’s holdings in Intuitive Surgical were worth $39,278,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Castleark Management LLC increased its position in shares of Intuitive Surgical by 3.4% during the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock valued at $47,221,000 after purchasing an additional 2,990 shares during the last quarter. Arlington Trust Co LLC increased its position in shares of Intuitive Surgical by 34.5% during the 1st quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider’s stock valued at $369,000 after purchasing an additional 191 shares during the last quarter. Aveo Capital Partners LLC increased its position in shares of Intuitive Surgical by 37.4% during the 1st quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider’s stock valued at $390,000 after purchasing an additional 198 shares during the last quarter. Aaron Wealth Advisors LLC increased its position in shares of Intuitive Surgical by 3.2% during the 1st quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider’s stock valued at $1,243,000 after purchasing an additional 78 shares during the last quarter. Finally, Longbow Finance SA increased its position in shares of Intuitive Surgical by 132.0% during the 1st quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider’s stock valued at $9,756,000 after purchasing an additional 11,209 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $449.98 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The company has a 50 day simple moving average of $489.31 and a two-hundred day simple moving average of $510.50. The firm has a market cap of $161.31 billion, a P/E ratio of 62.76, a price-to-earnings-growth ratio of 4.90 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same period last year, the firm posted $1.78 EPS. The company’s revenue was up 21.4% on a year-over-year basis. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several research reports. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $615.00 price target on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Citigroup reissued a “buy” rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a report on Wednesday, July 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $595.95.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Amy L. Ladd sold 335 shares of the stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director directly owned 739 shares of the company’s stock, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 in the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.